Zum Hauptinhalt springenSkip to page footer

Links zu Publikationen 2026

Publikationen 2026

1. 

In vitro modeling of inflammatory bowel diseases using a newly developed immunocompetent colon epithelial monolayer co-culture model. 

Larafa I, Zogorean R, Buehler A, Günther C, Wirtz S, Neurath MF, Thoma OM, Waldner MJ.

NPJ Biomed Innov. 2026 Jun 15;3(1):37. doi: 10.1038/s44385-026-00091-9.

PMID: 42298184      

2. 

IBDome: An integrated molecular, histopathological, and clinical atlas of inflammatory bowel diseases. 

Plattner C, Sturm G, Kühl AA, Atreya R, Carollo S, Rieder D, Gronauer R, Günther M, Ormanns S, Manzl C, Wirtz S, Meneghetti AR, Hegazy AN, Patankar JV, Carrero ZI, Grabherr F, Meyer M; TRR241 IBDome Consortium; Adolph TE, Tilg H, Neurath MF, Kather JN, Becker C, Siegmund B, Trajanoski Z.

Gastroenterology. 2026 Jun 10:S0016-5085(26)06947-7. doi: 10.1053/j.gastro.2026.05.023. Online ahead of print.

PMID: 42269946      

3. 

S1 Guideline: Therapy of generalized pustular psoriasis. 

Mößner R, Cramer N, Gerdes S, Hüffmeier U, Körber A, Krause K, Kromer C, Langen KA, Philipp S, Schäkel K, Schön MP, Schultheis M, Sollfrank L, Staubach P, Sticherling M, Wohlrab J, Wilsmann-Theis D, Paul C.

J Dtsch Dermatol Ges. 2026 Jun 14. doi: 10.1111/ddg.70244x. Online ahead of print.

PMID: 42290078      

4. 

Coordinated IFN-γ/TNF Axis Drives Selective Loss of Activated Enteric Glia in Inflammatory Bowel Diseases. 

Bubeck M, Penkert KA, Limberger H, Acera MG, Plattner C, Ziegler S, Muppirala A, Forster P, Jakob M, Gamez-Belmonte R, Erkert L, Kulkarni S, Günther C, Atreya R, Kühl AA, Hegazy AN, Hildner K, Trajanoski Z, Siegmund B, Neurath MF; IBDome Consortium; Rao M, Progatzky F, Lie DC, Becker C, Romagnani C, Ludwig LS, Klose CSN, Patankar JV.

Cell Mol Gastroenterol Hepatol. 2026 Jun 12:101827. doi: 10.1016/j.jcmgh.2026.101827. Online ahead of print.

PMID: 42285501      

5. 

Microbiota-specific serum IgG links gut and joints through immune-endothelial crosstalk in arthritis. 

Schmid E, Otterbein N, Ariyeloye S, Danzer H, Frech M, Naschberger E, Becerra MM, Sarter K, Schett G, Kastbom A, Svärd A, Wielockx B, Zaiss MM.

Front Microbiol. 2026 May 20;17:1821367. doi: 10.3389/fmicb.2026.1821367. eCollection 2026.

PMID: 42245507      Free PMC article.      

6. 

Boosting the Activity of Melanoma-Targeting CAR-T Cells in the Presence of Citrate by the Application of Gluconate. 

Harrer DC, Haferkamp S, Herr W, Mycielska M, Dörrie J, Schaft N, Abken H, Drexler K.

Pharmaceutics. 2026 Apr 30;18(5):551. doi: 10.3390/pharmaceutics18050551.

PMID: 42198246      Free PMC article.      

7. 

Management of Facial Immune Checkpoint Inhibitor-Induced Vitiligo with Topical Ruxolitinib: Quantitative Assessment Using a Semi-Automatic Tool. 

Breakell T, Neri P, Staats LAN, Kramer R, Berking C, Erdmann M, Hartmann A.

Curr Oncol. 2026 May 21;33(5):300. doi: 10.3390/curroncol33050300.

PMID: 42187617      Free PMC article.      

8. 

Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells. 

Rius Rigau A, Xu M, Liu Z, Chenguiti Fakhouri S, Auth J, Garantziotis P, Zoli A, Selvaraju MK, Raimondo MG, Tur C, Filla T, Gehringer P, Eckstein M, Müller F, Atzinger A, Ronicke M, Ekici A, Schmid R, Wirsching A, Hagen M, Böltz S, Krickau T, Horch RE, Berking C, Grieshaber-Bouyer R, Ramming A, Gupta P, Bozec A, Mackensen A, Distler JH, Schett G, Li YN, Bergmann C.

Nat Commun. 2026 May 23;17(1):4640. doi: 10.1038/s41467-026-72817-7.

PMID: 42177178      Free PMC article.      

9. 

Chimeric antigen receptor-based cellular therapy in autoimmune diseases: A systematic review and meta-analysis of clinical, serological and safety outcomes. 

Wong HJ, Lee ARYB, Yap QV, Chan E, Schett G, Tay SH.

Autoimmun Rev. 2026 Jul;25(7):104090. doi: 10.1016/j.autrev.2026.104090. Epub 2026 May 20.

PMID: 42167622      Review.      

10. 

Multimodal data integration to determine viral and innate immune kinetics in human airway epithelium. 

Lukas P, Gibeaud A, Schumer C, Arruda J, Guedj J, Terrier O, Graw F.

PLoS Comput Biol. 2026 May 20;22(5):e1014248. doi: 10.1371/journal.pcbi.1014248. eCollection 2026 May.

PMID: 42160356      Free PMC article.      

11. 

From complexity to clarity: aging bone marrow niche in bone and blood regeneration and malignancy. 

Roy N, Liu H, Horenberg AL, Pathak AP, Chen J, Ramasamy SK, Cohen-Solal M, Bozec A, Grayson WL, Kusumbe AP.

Bone Res. 2026 May 18;14(1):54. doi: 10.1038/s41413-026-00543-3.

PMID: 42151108      Free PMC article.      Review.      

12. 

Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial. 

Atreya R, Kühbacher T, Vieth M, Jefremow A, Hirschmann S, Waldner MJ, Fischer S, Vetter M, Drvarov O, Weigmann B, Meyer M, Mühl T, Homburg U, Sarigiannis G, Garn H, Renz H, Neurath MF.

Inflamm Bowel Dis. 2026 May 12:izag046. doi: 10.1093/ibd/izag046. Online ahead of print.

PMID: 42118952      

13. 

Authors' response to letter to editor-silencing GATA3: DNAzymes enter the therapeutic landscape of ulcerative colitis. 

Atreya R, Neurath MF.

Inflamm Bowel Dis. 2026 May 11:izag077. doi: 10.1093/ibd/izag077. Online ahead of print.

PMID: 42113907      No abstract available. 

14. 

Selective internal radiotherapy and chemosaturation show equivalent survival in metastatic uveal melanoma: a retrospective multicenter study. 

Koch EAT, Schielein LA, Reitmajer M, Glaser AC, Drexler K, Franklin C, Forschner A, Berking C, Hassel JC, Heppt MV; German Dermatologic Cooperative Oncology Group (DeCOG, Committee Ocular Melanoma).

Oncologist. 2026 May 8;31(6):oyag152. doi: 10.1093/oncolo/oyag152.

PMID: 42104930      Free PMC article.      

15. 

Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation. 

Picht S, Farrera-Sal M, Hiller AL, Brumhard S, Klaas AM, Schulenberg S, Friedrich R, Scholz C, Hemmerling L, Simon DN, Krönke G, Pichon C, Sander LE, Volk HD, Gossen M, Schmueck-Henneresse M, Drzeniek NM.

Mol Ther Nucleic Acids. 2026 Apr 28;37(2):102929. doi: 10.1016/j.omtn.2026.102929. eCollection 2026 Jun 16.

PMID: 42095134      Free PMC article.      

16. 

Case Report: Successful anti-TNF antibody therapy in steroid-dependent segmental colitis associated with diverticulosis and concomitant ulcerative colitis. 

Fousekis F, Siebler J, Rath T, Hartmann A, Neurath MF, Vieth M, Atreya R.

Front Immunol. 2026 Apr 15;17:1764305. doi: 10.3389/fimmu.2026.1764305. eCollection 2026.

PMID: 42064046      Free PMC article.      

17. 

Early Gut-Vascular Barrier Breakdown Precedes Colitis Onset in Murine Models. 

Mohamed Abdou M, Kreiß L, Schmid B, Thoma OM, Krüger R, Bénard A, Müller TM, Knauss A, Gabel M, González-Acera M, Lyu Y, Petter K, Lindemann A, Saad MSA, Eichhorn P, Becker C, Naschberger E, Zundler S, Weigmann B, Rath T, Atreya R, Kühl AA, Trajanoski Z; TRR241 IBDome Consortium; Friedrich O, Waldner MJ, Neurath MF, Herrmann M, Schürmann S, Britzen-Laurent N, Stürzl M.

Cell Mol Gastroenterol Hepatol. 2026 Apr 29;20(9):101795. doi: 10.1016/j.jcmgh.2026.101795. Online ahead of print.

PMID: 42061646      

18. 

Fibroblast dynamics in colorectal cancer: stability, plasticity, and novel markers. 

Demmler R, Anchang CG, Yong Y, Ramming A, Rauber S, Schellerer VS, Schmid B, Hartmann A, Merkel S, Imkeller K, Naschberger E, Stürzl M.

Oncogene. 2026 Jul;45(24):2299-2312. doi: 10.1038/s41388-026-03809-6. Epub 2026 Apr 28.

PMID: 42050076      Free PMC article.      

19. 

Small Subset, Big Impact: Regulatory Function of γδ T Cells in Arteriogenesis. 

Wimmer KS, Baur C, Kübler M, Arnholdt C, Kumaraswami K, Heim F, Elbs K, Rohrmoser MR, Merkus D, Deindl E.

Cells. 2026 Apr 17;15(8):709. doi: 10.3390/cells15080709.

PMID: 42041579      Free PMC article.      

20. 

Optoacoustic muscle imaging. 

Tan L, Meyer S, Zschüntzsch J, Rother U, Knieling F.

J Neuromuscul Dis. 2026 Apr 27:22143602261443594. doi: 10.1177/22143602261443594. Online ahead of print.

PMID: 42041250      Review.      

21. 

The Allium cepa Derived Compound Propyl Propane Thiosulfonate (PTSO) Improves Tumorigenesis Due to Its Immunomodulatory Effect: A Preclinical Study. 

Rodríguez-Sojo MJ, Hidalgo-García L, Molina-Tijeras JA, López-Escanez L, Gbati L, Vezza T, Diez-Echave P, Ruiz-Malagón AJ, García-García J, García F, Baños A, Gil-Martínez L, López-Posadas R, Neurath MF, Gálvez J, Rodríguez-Cabezas ME, Rodríguez-Nogales A.

Phytother Res. 2026 Apr 27. doi: 10.1002/ptr.70334. Online ahead of print.

PMID: 42037123      

22. 

Exploring Attitudes Toward AI-Based Contactless Sensors in Health Among Five Stakeholder Groups: Qualitative Study. 

Hille EM, Bleher H, Coppers B, Engelhardt S, Eskofier B, Garbe L, Heckel M, Liphardt AM, Manlig A, Rohleder N, Samhammer D, Spielmann C, Braun M.

J Med Internet Res. 2026 Apr 24;28:e75783. doi: 10.2196/75783.

PMID: 42030503      Free PMC article.      

23. 

A critical look at observational studies. 

Torgutalp M, Sahin D, Tascilar K.

Curr Opin Immunol. 2026 Jun;100:102778. doi: 10.1016/j.coi.2026.102778. Epub 2026 Apr 16.

PMID: 42000174      Review.      

24. 

Hospital resource use and costs in autoimmune encephalitis: a single-center retrospective cohort study. 

Keller N, Bertram D, Hamer H, Doerfler A, Schwab S, Rothhammer V, Tsaktanis T.

Neurol Res Pract. 2026 Apr 17;8(1):26. doi: 10.1186/s42466-026-00491-7.

PMID: 41998723      Free PMC article.      

25. 

Study protocol for testing pharmacological conditioning as a drug dose reduction strategy in patients with psoriasis in a randomised controlled trial. 

Savvidou P, Hölsken S, Krefting F, Benson S, Sondermann W.

BMJ Open. 2026 Apr 15;16(4):e114026. doi: 10.1136/bmjopen-2025-114026.

PMID: 41985954      Free PMC article.      

26. 

Targeting Blimp-1 in T cells results in activation of T-bet-mediated control of immunosuppression in lung cancer. 

Finotto S, Chiriac MT, Krammer S, Yang Z, Neurath L, Geppert CI, Nendel E, Trump S, Geiger A, Wirtz S, Zundler S, Neurath MF.

Cancer Immunol Immunother. 2026 Apr 15;75(5):144. doi: 10.1007/s00262-026-04381-4.

PMID: 41984247      Free PMC article.      

27. 

Low Energy and Protein Intake in Brain Tumor Patients Despite Higher Adiposity: A Comparative Study with Gastrointestinal Cancer. 

Povazay I, Burgard L, Herrmann HJ, Neurath MF, Eyüpoglu IY, Zopf Y.

Nutrients. 2026 Mar 26;18(7):1051. doi: 10.3390/nu18071051.

PMID: 41978102      Free PMC article.      

28. 

Transforming tumor cells into professional antigen-presenting cells using poly(β-amino ester) nanoparticles to deliver CD80-encoding mRNA. 

Binder AK, Bremm F, Feuchter N, Torres-Coll A, Kübel S, Berking C, Borrós S, Fornaguera C, Schaft N, Dörrie J.

Nanoscale Horiz. 2026 Apr 12. doi: 10.1039/d5nh00667h. Online ahead of print.

PMID: 41966140      

29. 

Hydrogen sulfide as a therapeutic candidate in diabetic retinopathy: a new perspective from gas medicine. 

Xue M, Dai W, Yuan S, Günther C.

Med Gas Res. 2026 Apr 11. doi: 10.4103/mgr.MEDGASRES-D-25-00186. Online ahead of print.

PMID: 41964596      No abstract available. 

30. 

CD19 CAR-T therapy induces remission in refractory autoimmune hemolytic anemia with ITP and antiphospholipid syndrome. 

Korte IK, Kharboutli S, Völkl S, Heberling L, Scholz JK, Pfeiffer H, Strobel J, Harrer T, Kretschmann S, Vasova I, Gerbitz A, Achenbach S, Spriewald B, Krause S, Gutsche K, von Bonin M, Röllig C, Aigner M, Mackensen A, Müller F.

Med. 2026 May 8;7(5):101075. doi: 10.1016/j.medj.2026.101075. Epub 2026 Apr 9.

PMID: 41962541      

31. 

Universal high-sensitivity CAR T-cell monitoring by targeting linker sequences. 

Schwingen NR, Meretuk L, Aigner M, Kretschmann S, Scholz JK, Gsottberger F, Harrer DC, Dingfelder J, Lutzny-Geier G, Kharboutli S, Mackensen A, Müller F, Völkl S.

Front Immunol. 2026 Mar 25;17:1787951. doi: 10.3389/fimmu.2026.1787951. eCollection 2026.

PMID: 41958667      Free PMC article.      

32. 

Why we need to maintain a critical view on big data and artificial intelligence predictions. 

Temiz A, Tascilar K.

Curr Opin Immunol. 2026 Jun;100:102776. doi: 10.1016/j.coi.2026.102776. Epub 2026 Apr 8.

PMID: 41955863      Review.      

33. 

Viral dynamics of the Respiratory Syncytial Virus during experimental human challenge: insights for transmission and protection. 

Schumer C, Mann AJ, Fourati S, Lukas P, Graw F, Catchpole A, Guedj J.

J Infect Dis. 2026 Apr 7:jiag206. doi: 10.1093/infdis/jiag206. Online ahead of print.

PMID: 41954922      

34. 

AnnexinA1-Dectin 1 axis is a key regulator of osteoclastogenesis underlying irradiation induced bone loss in male mice. 

Guliyeva G, Takile FNF, Stallfort V, Derer A, Frey B, Gupta P, Weber M, Trumet L, Schett G, Bozec A, Grötsch B.

J Bone Miner Res. 2026 Apr 2:zjag062. doi: 10.1093/jbmr/zjag062. Online ahead of print.

PMID: 41925240      

35. 

Pathophysiology of colitis-associated colorectal cancer. 

Neufert C, Neurath MF.

Nat Rev Gastroenterol Hepatol. 2026 Apr 1. doi: 10.1038/s41575-026-01197-6. Online ahead of print.

PMID: 41922722      Review.      

36. 

TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation. 

Ghirotto B, Gonçalves LE, Ruder V, James C, Gerasimova E, Rizo T, Wend H, Farrell M, Gerez JA, Prymaczok NC, Kuijs M, Shulman M, Hartebrodt A, Prots I, Gessner A, Vieth M, Zunke F, Winkler J, Blumenthal DB, Theis FJ, Riek R, Günther C, Neurath M, Gupta P, Winner B.

Nat Commun. 2026 Apr 1;17(1):3217. doi: 10.1038/s41467-026-71317-y.

PMID: 41922384      Free PMC article.      

37. 

Treatment with Sildenafil Promotes Angiogenesis and Modulates Immune Response in Ischemic Muscle Tissue. 

Kuhs A, Bobrowski L, Elbs K, Kübler M, Götz P, Arnholdt C, Lasch M, Deindl E.

Curr Issues Mol Biol. 2026 Mar 6;48(3):283. doi: 10.3390/cimb48030283.

PMID: 41899435      Free PMC article.      

38. 

Interferon-β and FTY720 ameliorate progressive CNS inflammation via SOCS1-associated astrocyte signaling. 

Tsaktanis T, Beyer T, Nirschl L, Rotaru AI, Engleitner T, Öllinger R, Zuber F, Peter A, Zissler J, Tschurl V, Linnerbauer M, Lößlein L, Vandrey O, Rad R, Korn T, Rothhammer V.

Sci Rep. 2026 Mar 25;16(1):9851. doi: 10.1038/s41598-026-45303-9.

PMID: 41882284      Free PMC article.      

39. 

Increased synovial and entheseal fibroblast activation detected by 68Ga-FAPI-PET/CT is associated with the development of psoriatic arthritis in psoriasis patients with arthralgia. 

Corte G, Atzinger A, Noversa de Sousa R, Mutlu MY, Temiz A, Bayat S, Raimondo MG, Ramming A, Sticherling M, Schmidkonz C, Kuwert T, Schett G, Tascilar K, Fagni F.

RMD Open. 2026 Mar 23;12(1):e006567. doi: 10.1136/rmdopen-2025-006567.

PMID: 41871918      Free PMC article.      

40. 

Human blood vessel organoids recapitulate key mechanisms of transition from vasculopathy to fibrosis in systemic sclerosis. 

Xiao Y, Hong X, Zhi L, Li YN, Regensburger M, Marxreiter F, Görg B, Koziel S, Györfi AH, Filla T, Bruch PM, Tripal P, Adjaye J, Dietrich S, Winkler J, Distler JHW, Matei AE.

Ann Rheum Dis. 2026 Mar 21:S0003-4967(26)00136-6. doi: 10.1016/j.ard.2026.02.021. Online ahead of print.

PMID: 41866288      

41. 

Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole-slide histopathology. 

Petzold A, Wessely A, Schliep S, Jiang H, Tran M, Koch EA, Peng T, Starz H, Berking C, Marr C, Heppt MV.

J Pathol Clin Res. 2026 Mar;12(2):e70082. doi: 10.1002/2056-4538.70082.

PMID: 41841638      Free PMC article.      

42. 

Paneth cells as orchestrators of epithelial barrier defense and emerging therapeutic targets in inflammatory bowel disease. 

Erkert L, Haag LM, Becker C.

Semin Immunopathol. 2026 Mar 16;48(1):1. doi: 10.1007/s00281-026-01068-x.

PMID: 41838175      Free PMC article.      Review.      

43. 

mRNA-based CAR T cell engineering: Unmodified mRNA enables high CAR expression without innate immune activation in T cells. 

Kahwaji N, Kotzian N, Prinz JM, Pu Y, Kath J, Picht S, Hiller AL, Klaas A, Dunne CM, Launspach M, Palmowski A, Kleyer A, Simon DN, Wagner DL, Pichon C, Krönke G, Schmueck-Henneresse M, Volk HD, Gossen M, Drzeniek NM.

Mol Ther Nucleic Acids. 2026 Jan 5;37(1):102805. doi: 10.1016/j.omtn.2025.102805. eCollection 2026 Mar 12.

PMID: 41834823      Free PMC article.      

44. 

Spatiotemporal molecular profiling of macrophage-fibroblast crosstalk defines checkpoints orchestrating onset and resolution of inflammation. 

Weishaupt K, Chambers D, Dzamukova M, Androšević I, Auger JP, Hueser D, Trzebanski S, Ramming A, Grüneboom A, Schett G, Jung S, Hoffmann MH, Krönke G.

Cell Rep. 2026 Mar 24;45(3):117091. doi: 10.1016/j.celrep.2026.117091. Epub 2026 Mar 14.

PMID: 41832953      

45. 

In-Person vs. Virtual: A Comparative Study of Teaching Methods in Nutritional Medicine.  

Trutwin BCR, Eilers J, Herrmann HJ, Neurath MF, Kohl M, Zopf Y, Burgard LC.

Nutrients. 2026 Mar 3;18(5):821. doi: 10.3390/nu18050821.

PMID: 41829991      Free PMC article.      Clinical Trial.      

46. 

Variability in BIA-Derived Muscle Mass Estimates: Device Choice Impacts Diagnostic Classification. 

Burgard LC, Goldschmidt S, Ohse VA, Herrmann HJ, Reljic D, Neurath MF, Zopf Y.

Nutrients. 2026 Feb 26;18(5):767. doi: 10.3390/nu18050767.

PMID: 41829937      Free PMC article.      

47. 

Metabolically reprogrammed eosinophils impair T cell immunity and cause chronic skin infection. 

Barinberg D, Sebald H, Gold T, Rai B, Radtke D, Lerm D, Voehringer D, Jantsch J, Wirtz S, Antonova AU, Colonna M, Bogdan C, Schleicher U.

EMBO Mol Med. 2026 Apr;18(4):1292-1317. doi: 10.1038/s44321-026-00392-x. Epub 2026 Mar 11.

PMID: 41813911      Free PMC article.      

48. 

MYH9 Variant p.(Arg424Gly) Alters Nonmuscle Myosin IIA Contraction, Causing Atypical MYH9-related Disease. 

Pollinger L, Greve JN, Grosch M, Kaliman S, Abuhattum S, Kräter M, Brauer I, Schaefer JT, Pasutto F, Wiesener A, Wopperer FJ, Kolb C, Lehmann CHK, Hoerning A, Daniel C, Amann K, Guck J, Schiffer M, Manstein DJ, Wiesener MS, Jobst-Schwan T.

Kidney Int Rep. 2026 Feb 3;11(4):106343. doi: 10.1016/j.ekir.2026.106343. eCollection 2026 Apr.

PMID: 41799362      Free PMC article.      

49. 

Beyond mobility: A prospective study on diet and metabolism in hereditary spastic paraplegia. 

Erhardt C, Spatz IT, Herrmann HJ, Kohl Z, Zopf Y, Gassner H, Winkler J, Regensburger M.

Metab Brain Dis. 2026 Mar 3;41(1):45. doi: 10.1007/s11011-026-01815-x.

PMID: 41774218      Free PMC article.      

50. 

Long-term osteoprotective effects of IL-17A blockade with secukinumab in psoriatic arthritis: data from the PSARTROS-II study. 

Schuster L, Temiz A, Mutlu MY, Tascilar K, Bayat S, Corte G, Rech J, Hueber A, Liphardt AM, Kleyer A, Simon D, Roemer F, Schett G, Fagni F.

RMD Open. 2026 Feb 25;12(1):e005857. doi: 10.1136/rmdopen-2025-005857.

PMID: 41741168      Free PMC article.      

51. 

CAR T-cell therapy in autoimmune skin disease. 

Schett A, Schett G.

J Eur Acad Dermatol Venereol. 2026 Mar;40(3):328-330. doi: 10.1111/jdv.70178.

PMID: 41738499      No abstract available. 

52. 

Melanoma of unknown primary shows an oncogenic pattern and clinical course of sun-exposed melanoma. 

Lodde G, Dollani J, Galetzka W, Mohr P, Meier F, Gutzmer R, Weichenthal M, Utikal J, Herbst R, Leiter U, Pföhler C, Schilling B, Terheyden P, Berking C, Sucker A, Stang A, Rambow F, Tilkorn D, Roesch A, Zaremba A, Zimmer L, Tasdogan A, Schadendorf D, Ugurel S, Griewank K, Livingstone E.

Br J Dermatol. 2026 Apr 17;194(5):843-853. doi: 10.1093/bjd/ljaf499.

PMID: 41719057      

53. 

Geometry of disordered porous environments regulates cell migration. 

Würthner L, Graw F.

Phys Rev E. 2026 Jan;113(1-1):014407. doi: 10.1103/hvtd-qwp1.

PMID: 41715819      

54. 

Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases. 

Düsing C, Györfi AH, Stütz AN, Lahu LM, Deicher FS, Li YN, Bruch PM, Matei AE, Micu A, Filla T, Koziel S, Hölscher AS, Röhrich M, Lorenz HM, Cramer M, Antoch G, Timm J, Abusabha Y, Ruck T, Homey B, Kreuter A, Buehring B, Radujkovic A, Heußel CP, Hagen M, Grieshaber-Bouyer R, Schett G, Brunn A, Dietrich S, Merkt W, Distler JHW.

Nat Med. 2026 Apr;32(4):1530-1542. doi: 10.1038/s41591-026-04238-4. Epub 2026 Feb 19.

PMID: 41714747      Free PMC article.      

55. 

Vision transformer-based diagnosis of psoriasis and eczema in whole-slide histology.  

Rivera Monroy LC, Petzold A, Sari M, Breininger K, Maier A, Vera-Gonzalez J, Erdmann M, Schliep S, Drexler K, Niebel D, Schreml S, Hayani KM, Aebischer V, Braun SA, Schmidle P, Metze D, Sticherling M, Berking C, Koch EAT, Heppt MV.

Virchows Arch. 2026 Feb 20. doi: 10.1007/s00428-026-04445-x. Online ahead of print.

PMID: 41714431      

56. 

Voclosporin shows protective effect and intestinal barrier enforcement in experimental colitis. 

Gabel M, Knauss A, Liu Y, Mohamed Abdou M, Kaufmann C, Loges L, Stürzl M, Schürmann S, Waldner MJ, Neurath MF, Weigmann B.

Front Med (Lausanne). 2026 Feb 2;13:1750826. doi: 10.3389/fmed.2026.1750826. eCollection 2026.

PMID: 41704697      Free PMC article.      

57. 

A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis. 

Makhzoum JP, Cid MC, Samson M, Henes J, Schönau V, Espigol-Frigole G, Ross C, Ahlman MA, Hsu MC, Li S, Verdijk P, Okonkwo L, Grayson PC, Blockmans D.

Ann Rheum Dis. 2026 May;85(5):911-920. doi: 10.1016/j.ard.2026.01.009. Epub 2026 Feb 12.

PMID: 41688258      Clinical Trial.      

58. 

Tools and advanced imaging technologies for assessing intestinal epithelial barrier integrity: a systematic review. 

Vieujean S, Atreya R, Buda A, Caradec J, Citi S, Danese S, Dewit O, Friedrich M, Ghosh S, Iacucci M, Jairath V, Kaser A, Leong RW, Neurath MF, Pierre N, Pohin M, Rath T, Rivière P, Travis S, Westcott J, Zeissig S, Peyrin-Biroulet L.

Am J Physiol Gastrointest Liver Physiol. 2026 Apr 1;330(4):G424-G458. doi: 10.1152/ajpgi.00447.2025. Epub 2026 Feb 12.

PMID: 41677575      Review.      

59. 

Reduced serum AHR agonistic activity reflects amyloid dysregulation in AT1 subtypes of Alzheimer's disease. 

Tsaktanis T, Rudtke L, Ammon L, Mestermann S, Rothhammer V, Lewczuk P, Maler JM, Kornhuber J, Oberstein TJ.

Alzheimers Res Ther. 2026 Feb 6;18(1):47. doi: 10.1186/s13195-026-01978-w.

PMID: 41652618      Free PMC article.      

60. 

Harnessing Digital Pathology Tools to Distinguish Hand Eczema From Palmar Psoriasis: A Quantitative Approach. 

Sari M, Schliep S, Petzold A, Kiesewetter F, Erdmann M, Sticherling M, Berking C, Heppt MV, Koch EAT.

J Cutan Pathol. 2026 May;53(5):444-453. doi: 10.1111/cup.70064. Epub 2026 Feb 5.

PMID: 41645409      Free PMC article.      

61. 

Simulation-based inference of cell migration dynamics in complex spatial environments. 

Arruda J, Alamoudi E, Mueller R, Vaisband M, Molkenbur R, Merrin J, Kiermaier E, Hasenauer J.

NPJ Syst Biol Appl. 2026 Jan 29;12(1):20. doi: 10.1038/s41540-026-00648-9.

PMID: 41611727      Free PMC article.      

62. 

Repurposing PDE5-Inhibitors: Sildenafil Drives Arteriogenesis via Localized Regenerative Inflammation. 

Elbs K, Bobrowski L, Arnholdt C, Kübler M, Götz P, Rohrmoser MR, Merkus D, Lasch M, Deindl E.

Int J Mol Sci. 2026 Jan 19;27(2):985. doi: 10.3390/ijms27020985.

PMID: 41596630      Free PMC article.      

63. 

Molecular stratification and transcriptome-guided therapeutics in systemic lupus erythematosus with insufficient treatment response. 

Beretta L, Chan CWS, Moysidou GS, Nöthling DM, Ainatzoglou A, Zoli A, Katechis S, Fanouriakis A, Bozec A, Sidiropoulos P, Bergmann C, Boumpas DT, Schett G, Bertsias G, Garantziotis P.

J Autoimmun. 2026 Mar;159:103525. doi: 10.1016/j.jaut.2026.103525. Epub 2026 Jan 21.

PMID: 41570368      

64. 

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy. 

Möhn N, Grote-Levi L, Bonifacius A, Tischer-Zimmermann S, Nay S, Jendretzky KF, Sassmann ML, Karacondi K, Zent M, Konen FF, Sühs KW, Meuth SG, Pawlitzki M, Warnke C, Ayzenberg I, Schneider R, Helmchen C, Brüggemann N, Klebe S, Hildner M, Grefkes C, Nitsch L, Hühnchen P, Böltz S, Alt L, Tumani H, Kleinschnitz C, Pul R, Grauer O, Clifford D, Gnanapavan S, Wicklein R, Perpoint T, Beudel M, Del Bello A, Rauer S, Wiendl H, Jelcic I, Gasnault J, Cimini E, Antinori A, Pinnetti C, Pourcher V, Weiss N, Lambert N, Maecker-Kolhoff B, Höglinger GU, Zahraeifard S, Cortese I, Eiz-Vesper B, Martin-Blondel G, Skripuletz T; Immunotherapy for PML Study Group.

JAMA Neurol. 2026 Mar 1;83(3):280-289. doi: 10.1001/jamaneurol.2025.5318.

PMID: 41557340      Free PMC article.      

65. 

Contemporary 0.55 T MRI to visualize interstitial lung disease - An exploratory study. 

Bayerl N, Mathy CS, Bergmann C, Bäuerle T, Adams LC, Nagel AM, Distler JHW, Gerhalter T, Uder M, Heiss R, Ellmann S.

Eur J Radiol Open. 2026 Jan 5;16:100720. doi: 10.1016/j.ejro.2025.100720. eCollection 2026 Jun.

PMID: 41550670      Free PMC article.      

66. 

Reply to Correspondence on: 'Effects of different B-cell-depleting strategies on the lymphatic tissue'. 

Tur C, Eckstein M, Rauber S, Schett G, Bozec A, Raimondo MG.

Ann Rheum Dis. 2026 Jan;85(1):e1-e2. doi: 10.1016/j.ard.2025.09.008. Epub 2025 Nov 12.

PMID: 41539838      No abstract available. 

67. 

A centrally positioned cluster of multiple centrioles in antigen-presenting cells fosters T cell activation. 

Stötzel I, Weier AK, Sarkar A, Som S, Bach L, Konopka P, Miková E, Ghosh S, Böthling J, Homrich M, Schaedel L, Kazmaier U, Symeonidis K, Ebner S, Weidner P, Abdullah Z, Meissner F, Uderhardt S, Hons M, Baumjohann D, Paul R, Rieger H, Kiermaier E.

Nat Commun. 2026 Jan 13;17(1):536. doi: 10.1038/s41467-026-68286-7.

PMID: 41530195      Free PMC article.      

68. 

Definition of predictive and prognostic immune biomarkers for salivary gland cancer from the intratumoural and systemic immune status: detailed protocol of the prospective, observatory ImmoGlandula study. 

Donaubauer AJ, Frey B, Agaimy A, Lange F, Mogge L, Fietkau R, Iro H, Munoz LE, Weber M, Kesting M, Gaipl US, Haderlein M, Müller S.

BMJ Open. 2026 Jan 12;16(1):e100021. doi: 10.1136/bmjopen-2025-100021.

PMID: 41526019      Free PMC article.      

69. 

Epigenetic Modulation of IL-7 and IL-10: Toward Personalized Immune Therapies in Viral Epidemics. 

Yulugkural Z, Yildiz M, Topcu E, Elmaslar Mert HT, Temiz A.

J Immunol Res. 2026 Jan 8;2026:9467657. doi: 10.1155/jimr/9467657. eCollection 2026.

PMID: 41523740      Free PMC article.      

70. 

Intestinal Sclerostin Deficiency Links Gut Dysbiosis to Altered Serotonin Homeostasis in Axial Spondyloarthritis. 

Mauro D, Bergot AS, Guggino G, Salzillo A, Forte G, Ciancio A, Rizzo A, Raimondo S, Lentini L, Gandolfo S, Kim SP, Wong C, De Marino B, Milling S, Alessandro R, Panarese I, Riddle RC, Zaiss MM, McGonagle D, Thomas R, Ciccia F.

Inflammation. 2026 Jan 10;49(1):38. doi: 10.1007/s10753-025-02393-3.

PMID: 41518441      Free PMC article.      

71. 

esloco: simulation-based estimation of local coverage in long-read DNA sequencing. 

Weich A, Lischer C, Vera J.

Bioinformatics. 2026 Jan 3;42(2):btag009. doi: 10.1093/bioinformatics/btag009.

PMID: 41512287      Free PMC article.      

72. 

Mucosal innate immune activation as the trigger to Prevotella species-induced arthritis in genetically resistant mice. 

Maeda Y, Rabenow M, Xiang W, Schmid E, Otterbein N, Gimaev I, Amend L, Riedinger L, Ehnes L, Miyagawa I, Sarfati I, Lesker TR, Danzer H, Sarter K, Dürholz K, Schälter F, Bao L, Wirtz S, Arnold P, Hofmann J, Pischetsrieder M, Sjöberg D, Svärd A, Kastbom A, Schett G, Strowig T, Zaiss MM.

Cell Rep. 2026 Jan 27;45(1):116755. doi: 10.1016/j.celrep.2025.116755. Epub 2026 Jan 5.

PMID: 41499240      

73. 

The role of the TIM-3 receptor in inflammatory bowel disease and autoimmunity: implications for TIM-3 and TCR crosstalk. 

Gabel M, Knauss A, Neurath MF, Weigmann B.

J Mol Med (Berl). 2026 Jan 2;104(1):20. doi: 10.1007/s00109-025-02631-z.

PMID: 41483156      Free PMC article.      Review.      

74. 

Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to joints. 

Raimondo MG, Mohammadian H, Angeli MR, Alivernini S, Fedorchenko V, Huang K, Demmler R, Rhein P, Xu C, Li YN, Micheroli R, Winter Z, Rigau AR, Anchang CG, Soare A, Luber M, Labinsky H, Chang J, Günther C, Fearon U, Veale DJ, Ciccia F, Rech J, Sticherling M, Bäuerle T, Distler JHW, Kurowska-Stolarska MS, Mack M, Ekici AB, Croft AP, Distler O, Maric HM, Ospelt C, Cañete JD, D'Agostino MA, Schett G, Rauber S, Ramming A.

Nat Immunol. 2026 Jan;27(1):35-47. doi: 10.1038/s41590-025-02351-z. Epub 2026 Jan 2.

PMID: 41482544      Free PMC article.      

75. 

T cell engagers emerge as a compelling therapeutic modality. 

Baeuerle PA, Sauer K, Grieshaber-Bouyer R, Michaelson JS.

J Exp Med. 2026 Feb 2;223(2):e20251652. doi: 10.1084/jem.20251652. Epub 2025 Dec 26.

PMID: 41474966      Review.      

76. 

Author Correction: E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis. 

Patankar JV, Müller TM, Kantham S, Acera MG, Mascia F, Scheibe K, Mahapatro M, Heichler C, Yu Y, Li W, Ruder B, Günther C, Leppkes M, Mathew MJ, Wirtz S, Neufert C, Kühl AA, Paquette J, Jacobson K, Atreya R, Zundler S, Neurath MF, Young RN, Becker C.

Nat Cell Biol. 2026 Feb;28(2):379. doi: 10.1038/s41556-025-01863-y.

PMID: 41429937      No abstract available. 

77. 

New insights into Th9 cells in inflammatory bowel diseases. 

Neurath MF.

Semin Immunol. 2026 Mar;81:102013. doi: 10.1016/j.smim.2025.102013. Epub 2025 Dec 16.

PMID: 41406701      Review.      

78. 

Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy. 

Dugas-Breit S, Forschner A, Erdmann M, Gutzmer R, Kähler KC, Holst I, Brekner A, Franklin C, Sindrilaru A, Zimmer L, Heinzerling L, Utikal J, Meier F, Bender A, Berking C, Garbe C, Weichenthal M, Schadendorf D, Hauschild A, Gschnell M, Mohr P, Hassel JC.

Eur J Cancer. 2026 Jan 17;233:116149. doi: 10.1016/j.ejca.2025.116149. Epub 2025 Nov 29.

PMID: 41385939      

79. 

Membrane Vesicles from Lacticaseibacillus Casei BL23 Exhibit Antimicrobial Activity Against Escherichia coli and Immunostimulatory Effects on Human Peripheral Blood Mononuclear Cells. 

D'Antoni CL, Pourtalebi Jahromi L, Sana L, Domínguez Rubio AP, Dorfner M, Munkert J, Danzer H, Arnold P, Lebedev M, Zanin E, Pérez OE, Fuhrmann G.

Adv Healthc Mater. 2026 Apr;15(16):e00548. doi: 10.1002/adhm.202500548. Epub 2025 Dec 5.

PMID: 41351206      Free PMC article.      

80. 

Fcγ-receptor-activation by circulating immune complexes in systemic autoimmune diseases and its reduction by CD19-CAR T cell therapy. 

Freitag M, Kolb P, Falcone V, Claus M, Schröder P, Andreeva I, Rodon L, Ewald M, Deicher FS, Stütz AN, Distler JHW, Blank N, Grieshaber-Bouyer R, Muñoz LE, Lorenz HM, Schett G, Merkt W.

Rheumatology (Oxford). 2026 Mar 5;65(3):keaf627. doi: 10.1093/rheumatology/keaf627.

PMID: 41335463      Free PMC article.      

81. 

Neutrophil Transmigration Analyses for Multiplexed Drug Screening and In Vivo Like Application Testing Using an Organ on a Chip Model. 

Reichardt CM, Muñoz LE.

Methods Mol Biol. 2026;2990:97-104. doi: 10.1007/978-1-0716-4997-8_8.

PMID: 41269551      

82. 

Dual targeting of TNF and IL-23 by a bispecific antibody in ulcerative colitis. 

Atreya R, Neurath MF.

Lancet Gastroenterol Hepatol. 2026 Jan;11(1):5-6. doi: 10.1016/S2468-1253(25)00330-9. Epub 2025 Nov 13.

PMID: 41242335      No abstract available. 

83. 

Confounding by indication in observational studies investigating glucocorticoid-associated adverse events in patients with rheumatoid arthritis: a systematic literature review including an assessment of E-values. 

Palmowski A, Beenken AE, Pankow A, Oldenkott J, Käding H, Wiebe E, Boyadzhieva Z, Matteson EL, Minopoulou I, Witte T, Simon D, Boers M, Kleyer A, Buttgereit F.

Ann Rheum Dis. 2026 Mar;85(3):580-583. doi: 10.1016/j.ard.2025.10.008. Epub 2025 Nov 13.

PMID: 41238491      No abstract available. 

84. 

Lifestyle medicine in Parkinson's disease. 

Süß P, Regensburger M, Gassner H, Winkler J.

J Neural Transm (Vienna). 2026 Feb;133(2):279-295. doi: 10.1007/s00702-025-03059-y. Epub 2025 Nov 12.

PMID: 41222709      Free PMC article.      Review.      

85. 

Myosin II regulates cellular thermo-adaptability and the efficiency of immune responses. 

Company-Garrido I, Zurita Carpio A, Colomer-Rosell M, Ciraulo B, Molkenbur R, Lanzerstorfer P, Pezzano F, Agazzi C, Hauschild R, Jain S, Jacques JM, Venturini V, Knapp C, Xie Y, Merrin J, Weghuber J, Schaaf M, Quidant R, Kiermaier E, Ortega Arroyo J, Ruprecht V, Wieser S.

Dev Cell. 2026 Feb 11;61(2):356-371.e12. doi: 10.1016/j.devcel.2025.10.006. Epub 2025 Nov 4.

PMID: 41192429      

86. 

CAR T-cell therapy in systemic sclerosis: the next frontier in immune modulation.  

Garantziotis P, Auth J, Schett G, Bergmann C.

Curr Opin Rheumatol. 2026 Jan 1;38(1):60-68. doi: 10.1097/BOR.0000000000001133. Epub 2025 Oct 30.

PMID: 41185148      Review.      

87. 

Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study. 

Raimondo MG, Mohammadian H, Rauber S, Alivernini S, Fedorchenko V, Rigau AR, Angeli MR, Fagni F, Corte G, Tascilar K, Labinsky H, Ramming AM, Roemer F, Rech J, Braeuer L, D'Agostino MA, Schett G, Pachowsky M, Kleyer A, Ramming A.

Ann Rheum Dis. 2026 Feb;85(2):285-296. doi: 10.1016/j.ard.2025.08.032. Epub 2025 Oct 16.

PMID: 41107119      

88. 

Predicting Treatment Outcomes in Patients With Psoriatic Arthritis or Axial Spondyloarthritis: An Artificial Intelligence-Driven Approach. 

Vodenčarević A, Brandt-Juergens J, Bär S, Kästner P, Köhm M, Simon D, Behrens F, Glassen T, Gmeiner B, Peterlik D, Kiltz U.

J Rheumatol. 2026 Feb 1;53(2):152-161. doi: 10.3899/jrheum.2025-0327.

PMID: 41093647      

89. 

Response to 'Comment on "Efficacy of interventions for Bowen's disease"'. 

Petzold A, Heppt MV.

J Eur Acad Dermatol Venereol. 2026 Jun;40(6):e530-e531. doi: 10.1111/jdv.70076. Epub 2025 Oct 1.

PMID: 41031419      No abstract available. 

90. 

Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction Model. 

Lanzillotta M, Macinga P, Poulsen JL, Vinge-Holmquist O, Demirci AF, Tacelli M, Backhus J, Algül H, Descourvieres C, Kiriukova M, Goni E, Hollenbach M, Miksch RC, Kunovsky L, Vujasinovic M, Nikolic S, Dickerson L, Hirth M, Neurath MF, Zumblick M, Vila J, Jalal M, Beyer G, Frost F, Carrara S, Kala Z, Jabandziev P, Sisman G, Akyuz F, Capurso G, Falconi M, Arlt A, Vleggaar FP, Barresi L, Greenhalf B, Czakó L, Hegyi P, Hopper A, Nayar MK, Gress TM, Vitali F, Schneider A, Halloran CM, Trna J, Okhlobystin AV, Dagna L, Cahen DL, Bordin D, Rebours V, Mayerle J, Kahraman A, Rasch S, Culver E, Kleger A, Martínez-Moneo E, Hucl T, Olesen SS, Bruno MJ, Beuers U, Della-Torre E, Löhr JM, Rosendahl J, Overbeek KA; PrescrAIP Study Group.

Clin Gastroenterol Hepatol. 2026 May;24(5):1321-1331. doi: 10.1016/j.cgh.2025.09.005. Epub 2025 Sep 13.

PMID: 40953780      

91. 

[Amniotic membrane-covered bioimplants for treatment of severe pseudomembranous keratoconjunctivitis in two patients with erythema exsudativum multiforme following pneumonia caused by Mycoplasma pneumoniae]. 

Voulgari T, Heppt MV, Steinhorst K, Kruse FE, Weller JM.

Ophthalmologie. 2026 Jan;123(1):67-70. doi: 10.1007/s00347-025-02317-4. Epub 2025 Aug 29.

PMID: 40879749      German.      No abstract available. 

92. 

Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigus. 

Didona D, Hudemann C, Garn H, Krzikalla D, Wang SH, Hinterseher J, Volkmann K, Polakova A, Zakrzewicz A, Feldhoff S, Tikkanen R, Digigow R, Pfützner W, Santos A, Zimmer CL, Hahmann M, Harnisch S, Rösch S, Huguenin S, Eming R, Hahn M, Schauer F, Antiga E, Senatore S, Maglie R, Täubel J, Ghoreschi K, Meier K, Solimani F, Sticherling M, Sollfrank L, Günther C, Steinbrink K, Magnolo N, van Schaick E, Asnaghi V, Zollmann FS, Pohlner J, Hummel J, Sandbrink R, de Min C, Fleischer S, Möbs C, Hertl M.

Br J Dermatol. 2026 Jan 6;194(1):86-98. doi: 10.1093/bjd/ljaf311.

PMID: 40795222      Clinical Trial.      

93. 

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus. 

Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber-Bouyer R, Hagen M, Bergmann C, Wirsching A, Bozec A; PRECISESADS Clinical Consortium; Schneider M, Barturen G, Bertsias G, Boumpas DT, Alarcón-Riquelme ME, Mackensen A, Schett G, Parodis I.

Ann Rheum Dis. 2026 Jan;85(1):153-163. doi: 10.1016/j.ard.2025.06.2132. Epub 2025 Jul 23.

PMID: 40701862      

94. 

Bioengineered Bacterial Vesicles and Biomimetic Hybrids Eliminate Biofilms and Balance the Gut Microbiome. 

Pourtalebi Jahromi L, Kronast B, Munkert J, Sana L, Koch M, Danzer H, Dormeyer S, Jiang S, Herrmann F, Weiler M, Kashkanova A, Sandoghdar V, Zaiss MM, Fuhrmann G.

Small. 2026 Mar;22(16):e2502551. doi: 10.1002/smll.202502551. Epub 2025 Jul 22.

PMID: 40693324      Free PMC article.      

95. 

Calibration-free Laser-induced Breakdown Spectroscopy (CF-LIBS): Plasma criteria for porcine tissue. 

Böhmer E, Degelmann LS, Thoma OM, Waldner MJ, Mehari F, Klämpfl F, Hohmann M, Schmidt M.

Talanta. 2026 Jan 1;297(Pt A):128545. doi: 10.1016/j.talanta.2025.128545. Epub 2025 Jul 15.

PMID: 40680366      

96. 

Deep learning-based classification of erosion, synovitis and osteitis in hand MRI of patients with inflammatory arthritis. 

Schlereth M, Mutlu MY, Utz J, Bayat S, Heimann T, Qiu J, Ehring C, Liu C, Uder M, Kleyer A, Simon D, Roemer F, Schett G, Breininger K, Fagni F.

RMD Open. 2024 Jun 17;10(2):e004273. doi: 10.1136/rmdopen-2024-004273.

PMID: 38886001      Free PMC article.      

97. 

Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids. 

Auger JP, Zimmermann M, Faas M, Stifel U, Chambers D, Krishnacoumar B, Taudte RV, Grund C, Erdmann G, Scholtysek C, Uderhardt S, Ben Brahim O, Pascual Maté M, Stoll C, Böttcher M, Palumbo-Zerr K, Mangan MSJ, Dzamukova M, Kieler M, Hofmann M, Blüml S, Schabbauer G, Mougiakakos D, Sonnewald U, Hartmann F, Simon D, Kleyer A, Grüneboom A, Finotto S, Latz E, Hofmann J, Schett G, Tuckermann J, Krönke G.

Nature. 2024 May;629(8010):184-192. doi: 10.1038/s41586-024-07282-7. Epub 2024 Apr 10.

PMID: 38600378      

98. 

Physical Function of RA patients Tapering Treatment-A Post Hoc Analysis of the Randomized Controlled RETRO Trial. 

Stephan M, Tascilar K, Yalcin-Mutlu M, Hagen M, Haschka J, Reiser M, Hartmann F, Kleyer A, Hueber AJ, Manger B, Figueiredo C, Cobra JF, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nüsslein H, Alten R, Henes J, Krüger K, Schett G, Rech J.

J Clin Med. 2023 May 28;12(11):3723. doi: 10.3390/jcm12113723.

PMID: 37297917      Free PMC article.      

99. 

Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. 

Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, Völkl S, Simon D, Kleyer A, Munoz L, Kretschmann S, Kharboutli S, Gary R, Reimann H, Rösler W, Uderhardt S, Bang H, Herrmann M, Ekici AB, Buettner C, Habenicht KM, Winkler TH, Krönke G, Schett G.

Nat Med. 2023 Nov;29(11):2956. doi: 10.1038/s41591-022-02091-9.

PMID: 36329355      No abstract available. 

100. 

Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care consultation: results of a multicenter-based study. 

Fuchs F, Morf H, Mohn J, Mühlensiepen F, Ignatyev Y, Bohr D, Araujo E, Bergmann C, Simon D, Kleyer A, Vorbrüggen W, Ramming A, Distler JHW, Bartz-Bazzanella P, Schett G, Welcker M, Hueber AJ, Knitza J.

Rheumatol Int. 2023 Mar;43(3):495-502. doi: 10.1007/s00296-022-05223-z. Epub 2022 Oct 10.

PMID: 36214864      Free PMC article.      

101. 

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. 

Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, Völkl S, Simon D, Kleyer A, Munoz L, Kretschmann S, Kharboutli S, Gary R, Reimann H, Rösler W, Uderhardt S, Bang H, Herrmann M, Ekici AB, Buettner C, Habenicht KM, Winkler TH, Krönke G, Schett G.

Nat Med. 2022 Oct;28(10):2124-2132. doi: 10.1038/s41591-022-02017-5. Epub 2022 Sep 15.

PMID: 36109639      

102. 

Comparison of physician and artificial intelligence-based symptom checker diagnostic accuracy. 

Gräf M, Knitza J, Leipe J, Krusche M, Welcker M, Kuhn S, Mucke J, Hueber AJ, Hornig J, Klemm P, Kleinert S, Aries P, Vuillerme N, Simon D, Kleyer A, Schett G, Callhoff J.

Rheumatol Int. 2022 Dec;42(12):2167-2176. doi: 10.1007/s00296-022-05202-4. Epub 2022 Sep 10.

PMID: 36087130      Free PMC article.      

103. 

Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination. 

Fagni F, Schmidt K, Bohr D, Valor-Méndez L, Hartmann F, Tascilar K, Manger K, Manger B, Kleyer A, Simon D, Schett G, Harrer T.

RMD Open. 2022 May;8(1):e002323. doi: 10.1136/rmdopen-2022-002323.

PMID: 35589333      Free PMC article.      No abstract available. 

104. 

Performance of a Handheld Ultrasound Device to Assess Articular and Periarticular Pathologies in Patients with Inflammatory Arthritis. 

Corte G, Bayat S, Tascilar K, Valor-Mendez L, Schuster L, Knitza J, Fagni F, Schett G, Kleyer A, Simon D.

Diagnostics (Basel). 2021 Jun 22;11(7):1139. doi: 10.3390/diagnostics11071139.

PMID: 34206675      Free PMC article.      

105. 

Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion. 

Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss MM, Heppt F, Meder C, Atreya R, Klenske E, Dietrich P, Abdullah A, Kliem T, Corte G, Morf H, Leppkes M, Kremer AE, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Maier C, Hueber AJ, Manger K, Manger B, Berking C, Tenbusch M, Überla K, Sticherling M, Neurath MF, Schett G.

Nat Commun. 2020 Jul 24;11(1):3774. doi: 10.1038/s41467-020-17703-6.

PMID: 32709909      Free PMC article.      

106. 

Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. 

Tajik N, Frech M, Schulz O, Schälter F, Lucas S, Azizov V, Dürholz K, Steffen F, Omata Y, Rings A, Bertog M, Rizzo A, Iljazovic A, Basic M, Kleyer A, Culemann S, Krönke G, Luo Y, Überla K, Gaipl US, Frey B, Strowig T, Sarter K, Bischoff SC, Wirtz S, Cañete JD, Ciccia F, Schett G, Zaiss MM.

Nat Commun. 2020 Apr 24;11(1):1995. doi: 10.1038/s41467-020-15831-7.

PMID: 32332732      Free PMC article.      

107. 

JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function. 

Adam S, Simon N, Steffen U, Andes FT, Scholtysek C, Müller DIH, Weidner D, Andreev D, Kleyer A, Culemann S, Hahn M, Schett G, Krönke G, Frey S, Hueber AJ.

Sci Transl Med. 2020 Feb 12;12(530):eaay4447. doi: 10.1126/scitranslmed.aay4447.

PMID: 32051226